We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation.
- Authors
Jayasinghe, Thilini N.; Chiavaroli, Valentina; Holland, David J.; Cutfield, Wayne S.; O'Sullivan, Justin M.
- Abstract
Obesity has reached epidemic proportions. Despite a better understanding of the underlying pathophysiology and growing treatment options, a significant proportion of obese patients do not respond to treatment. Recently, microbes residing in the human gastrointestinal tract have been found to act as an "endocrine" organ, whose composition and functionality may contribute to the development of obesity. Therefore, fecal/gut microbiome transplantation (GMT), which involves the transfer of feces from a healthy donor to a recipient, is increasingly drawing attention as a potential treatment for obesity. Currently the evidence for GMT effectiveness in the treatment of obesity is preliminary. Here, we summarize benefits, procedures, and issues associated with GMT, with a special focus on obesity.
- Subjects
OBESITY treatment; METABOLIC disorders; GUT microbiome; ENDOCRINE glands; AMERICAN Medical Association; PREVENTION
- Publication
Frontiers in Cellular & Infection Microbiology, 2016, Vol 6, p1
- ISSN
2235-2988
- Publication type
Article
- DOI
10.3389/fcimb.2016.00015